Answers are grounded in this paper and cite their sources.
PROBLEM: To determine whether the expression of tumor necrosis factor (TNF-alpha) correlates with TNF-alpha receptor expression in human endometrium. METHOD OF STUDY: A multiprimer synthetic cDNA standard template containing complimentary sequences for several cytokines including TNF-alpha and TNF-alpha receptor type 2 was constructed and used in quantitative reverse transcription polymerase chain reaction (Q-RT-PCR). RESULTS: Endometrium from proliferative phase of the menstrual cycle expresses higher levels of TNF-alpha mRNA (2.35 +/- 0.2 x 10(5) copies/microg of total cellular RNA) than secretory phase ([1.3 +/- 0.08 x 10(5) copies] P < 0.05), with a significant reduction during menses (1.2 +/- 0.1 x 10(4) copies) and postmenopausal period (8.1 +/- 1.6 x 10(4) copies [P < 0.05]). In contrast, TNF-alpha type 1 receptor mRNA expression was higher in endometrium from the secretory phase (6.6 +/- 0.6 x 10(7) copies) compared to the menses (5.1 +/- 0.5 x 10(6) copies), proliferative phase (1.9 +/- 0.1 x 10(6) copies) and postmenopausal period (5.8 +/- 0.7 x 10(4) copies [P < 0.05]). Comparatively, TNF-alpha receptor type 2 is expressed 10 to 100 fold higher in the endometrium than TNF-alpha (P < 0.05). CONCLUSION: The data confirm that human endometrium expresses TNF-alpha; and provide the first evidence that TNF-alpha expression is inversely related to TNF-alpha type 1 receptor expression during the menstrual cycle. Such an inverse relation between TNF-alpha and TNF-alpha receptor expression may provide a regulatory mechanism necessary to overcome the detrimental effect of high levels of TNF-alpha on various endometrial cell types.
No takes yet. Share an insight, caveat, or question.
Chegini et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: